Unique ID issued by UMIN | UMIN000022128 |
---|---|
Receipt number | R000025494 |
Scientific Title | Investigation of the effects of Longvida on cognitive functions in a healthy population: a double-blind, randomized placebo-controlled and parallel study |
Date of disclosure of the study information | 2016/05/02 |
Last modified on | 2018/10/30 09:28:25 |
Investigation of the effects of Longvida on cognitive functions in a healthy population: a double-blind, randomized placebo-controlled and parallel study
Investigation of the effects of Longvida on cognitive functions
Investigation of the effects of Longvida on cognitive functions in a healthy population: a double-blind, randomized placebo-controlled and parallel study
Investigation of the effects of Longvida on cognitive functions
Japan |
decline of cognitive function
Adult |
Others
NO
To investigate the effect of the test food to improve cognition in healthy older Japanese adults
Safety,Efficacy
Repeatable Battery for the Assessment of Neuropsychological Status
Hasegawa dementia rating scale
Subjective symptoms: intake 0, 2, 4, 6, 8, 10, 12 weeks
Safety(blood test, history taking):intake 0, 12 weeks
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Longvida 400mg/day, 12weeks
Placebo, 12weeks
50 | years-old | <= |
80 | years-old | > |
Male and Female
1)Subjects aged from 50 to 79 years old
2)Japanese male and female
3)Having cognitive complaints
4)Nonsmoker
5)HDS-R score more than 16 points at screening test
1)Patients under medical treatment
2)Patients under dietetic treatment or ergotherapy
3)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., liver, kidney, endocrine, cardiovascular system, digestive organ, lung, blood, and/or metabolism).
4)Subjects who have undergone gastrointestinal tract surgery; except appendectomy.
5)Subjects who have previous medical history and/or current medical history of mental disorder.
6)Subjects who have previous medical history of drug and/or food allergy.
7)Subjects who have previous medical history and/or current medical history of drug dependence and/or drug abuse.
8)Subjects who participate in other clinical trial within a month
9)Subjects who work time is irregular.
10)Subjects who have previous medical history and/or current medical history of alcoholism
11)Subjects who are in receipt of public assistance
12) Subjects who have been determined ineligible by principal investigator or sub-investigator.
60
1st name | |
Middle name | |
Last name | Yutaka Kondo |
Omnica Co.,Ltd
Research team
TN Koishikawa BLDG. 5F, 1-15-17 Koishikawa, Bunkyo-ku, Tokyo, JAPAN
03-5840-9815
kondo@omnica.co.jp
1st name | |
Middle name | |
Last name | Satomi Iwata |
Omnica Co.,Ltd
Research team
TN Koishikawa BLDG. 5F, 1-15-17 Koishikawa, Bunkyo-ku, Tokyo, JAPAN
03-5840-9815
iwata@omnica.co.jp
HUMA R&D Co.
Omnica Co.,Ltd
Profit organization
NO
2016 | Year | 05 | Month | 02 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 08 | Day |
2016 | Year | 05 | Month | 02 | Day |
2016 | Year | 04 | Month | 28 | Day |
2018 | Year | 10 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025494
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |